Editorial Board Member

Jose J. G. Marin
Laboratory of Experimental Hepatology and Drug Targeting (HEVEPHARM), Institute for Biomedical Investigation of Salamanca (IBSAL), Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain; National Center for the Study of Liver and Digestive Diseases (CIBEREHD), Carlos III National Institute of Health, Madrid, Spain.
HomePage
Research Interests
liver cancer, chemoresistance characterization and sensitization, drug targeting, gene therapy strategies
Contributions:

Pharmacogenetics of hepatocellular carcinoma and cholangiocarcinoma

Impact of genetic variants in the solute carrier (SLC) genes encoding drug uptake transporters on the response to anticancer chemotherapy

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/